» Articles » PMID: 26389080

Pulmonary Hypertension and Cardiopulmonary Exercise in Heart Failure

Overview
Journal Pulse (Basel)
Date 2015 Sep 22
PMID 26389080
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In heart failure (HF), pulmonary hypertension (PH) is initially associated with a rise in the left ventricular filling pressure. PH is defined by pulmonary hemodynamic measurements including pulmonary capillary wedge pressure, mean pulmonary arterial pressure and pulmonary vascular resistance. Eventually, PH in HF may become more of a reactive process. Although the mechanism of the reactive PH development is not clearly understood, vascular dysfunction induced by remodeling, vasoactive substances and genetic variation appear to contribute significantly to this form of PH. Noninvasive cardiopulmonary exercise testing has been extensively utilized to assess disease severity in HF patients. It provides integrated information that is dependent on cardiopulmonary hemodynamics, lung mechanics, breathing pattern and strategy. In this review, we will discuss the mechanisms of PH development in HF and how noninvasive gas exchange measures obtained with submaximal exercise are influenced by PH in this population.

Citing Articles

Cardiopulmonary rehabilitation program impact on prognostic markers in selected patients with resting and exercise-induced ventilatory inefficiency: a clinical trial.

Mehani S, Abdeen H J Phys Ther Sci. 2017; 29(10):1803-1810.

PMID: 29184292 PMC: 5684013. DOI: 10.1589/jpts.29.1803.


Editorial.

Park J, Suzuki H Pulse (Basel). 2015; 1(3-4):186-7.

PMID: 26587437 PMC: 4315354. DOI: 10.1159/000362941.

References
1.
Moraes D, Colucci W, Givertz M . Secondary pulmonary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation. 2000; 102(14):1718-23. DOI: 10.1161/01.cir.102.14.1718. View

2.
Kim C, Anderson S, MacCarter D, Johnson B . A multivariable index for grading exercise gas exchange severity in patients with pulmonary arterial hypertension and heart failure. Pulm Med. 2013; 2012:962598. PMC: 3549363. DOI: 10.1155/2012/962598. View

3.
Olson T, Snyder E, Frantz R, Turner S, Johnson B . Repeat length polymorphism of the serotonin transporter gene influences pulmonary artery pressure in heart failure. Am Heart J. 2007; 153(3):426-32. DOI: 10.1016/j.ahj.2006.12.011. View

4.
Galie N, Hoeper M, Humbert M, Torbicki A, Vachiery J, Barbera J . Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the.... Eur Heart J. 2009; 30(20):2493-537. DOI: 10.1093/eurheartj/ehp297. View

5.
Guazzi M . Alveolar gas diffusion abnormalities in heart failure. J Card Fail. 2008; 14(8):695-702. DOI: 10.1016/j.cardfail.2008.06.004. View